Tag: #M&A

Angelini Pharma, a historic Italian family-owned company, has announced a $4.1 billion agreement to acquire Florida-based Catalyst Pharmaceuticals. This marks... Read more

Roche has announced a definitive merger agreement to acquire PathAI, a leader in digital pathology and AI-powered technology. This acquisition... Read more

Bayer has agreed to acquire San Francisco-based biotech startup Perfuse Therapeutics in a deal potentially worth $2.45 billion. This marks... Read more

Merck (known as MSD outside the U.S. and Canada) has announced the successful completion of its acquisition of Terns Pharmaceuticals.... Read more

Teva Pharmaceuticals has proposed the acquisition of Emalex Biosciences, a move that integrates a promising pediatric Tourette syndrome therapy into... Read more

UCB has entered into a definitive agreement to acquire Candid Therapeutics, securing the rights to cizutamig—a promising bispecific antibody for... Read more

Siegfried Holding AG has finalized the acquisition of Noramco, Extractas Biosciences, and Purisys from affiliates of SK Capital Partners. This... Read more

Cardioline, a leader in cardiac diagnostics and telecardiology, has announced the acquisition of Cardios, a Brazil-based innovator in Holter monitoring... Read more

Chiesi has announced the largest acquisition in its 90-year history, agreeing to purchase KalVista Pharmaceuticals for approximately $1.9 billion. This... Read more